Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

5.06
BATS BZX Real-Time Price
As of 12:35pm ET
 +0.02 / +0.40%
Today’s Change
4.82
Today|||52-Week Range
9.35
-19.55%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close5.04
Today’s open4.99
Day’s range4.88 - 5.11
Volume128,780
Average volume (3 months)329,996
Market cap$211.3M
Dividend yield--
Data as of 12:21pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,061.54%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.45%
P/E ratioNM
Price/Sales3.73
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...-0.14-2.89%
MRNSMarinus Pharmaceutic...-0.15-1.00%
ALIMAlimera Sciences Inc-0.06-1.28%
HSKAHeska Corp+2.13+6.66%
Data as of 12:36pm ET, 07/30/2015

Financials

Last reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$70.4M
Annual profit (last year)$5.5M
Net profit margin7.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts